A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening

Accurate patient-derived models of cancer are needed for profiling the disease and for testing therapeutics. These models must not only be accurate, but also suitable for high-throughput screening and analysis. Here we compare two derivative cancer models, microtumors and spheroids, to the gold stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Stackhouse, Christian T., Rowland, James R., Shevin, Rachael S., Singh, Raj, Gillespie, G. Yancey, Willey, Christopher D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678976/
https://www.ncbi.nlm.nih.gov/pubmed/31336733
http://dx.doi.org/10.3390/cells8070702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678976/
https://www.ncbi.nlm.nih.gov/pubmed/31336733
http://dx.doi.org/10.3390/cells8070702

Ejemplares similares